Vraylar® (cariprazine) – New indication
May 28, 2019 - Allergan and Gedeon Richter announced the FDA approval of Vraylar (cariprazine), for treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults.
Download PDF
